July PBAC marked by firsts

Posted 5 July 2021 AM

It's the first time PBAC will consider resubmissions through the early re-entry pathway as well as reviews of positive recommendations not accepted by applicants or "use it or lose it" reviews, slightly bumping up the workload for the committee at its meeting this week.

The meeting, which runs from Wednesday to Friday, will consider a total of 11 drugs under these two new categories plus thirty-six other submissions.

To see the whole article, please login